Artikel von Marvin Herzberger
Marvin Herzberger is a publishing trader at TraderFox GmbH and group leader for the technical analysis of the DAX. He has been actively engaged in technical analysis since 2011. In this context, he has tested, analyzed, and evaluated various trading strategies in practical implementation. His area of expertise lies in swing trading. The analyses cover a short-term time horizon of up to 10 days.Latest from Marvin Herzberger
Unity Software: Deal with Google attracts attention in the gaming industry - Emerging AI gaming market in focus!
Unity Software benefits from a far-reaching collaboration with Google for AI-driven game development....
Chewy Inc.: Analysts from Morgan Stanley see 100% price potential in the subscription model!
Morgan Stanley confirms the buy recommendation for Chewy Inc. (CHWY) with a price target of $36, supported...
Redcare Pharmacy: For me, the forecast upgrade was a buying trigger!
Redcare Pharmacy (i.) is on a strong growth path thanks to the digitization of the German healthcare...
ServiceNow: Bundesliga Partnership Reinforces AI Focus in CRM!
ServiceNow drives growth through AI solutions and aims for an AI contract value of $1.5 billion by...
Charles River Laboratories: Digital Boost through Apollo Orchestrate and New Long-Term Goals
The company aims for an annual organic revenue growth of 5 to 7% from 2027 to 2030, as well as an operating...
Compass Inc.: Anywhere Merger Sparks New Market Enthusiasm - Barclays Sees 70% Price Potential
The technology-based business model of Compass Inc. (COMP) significantly benefits from market consolidation...
Vistra: Nuclear Power as the Key to the Energy Hunger of the AI Era - Experts See a Further 34% Price Potential!
Transformation: Vistra establishes itself as a strategic energy partner through the AI boom. Current...
Genmab: Oncology Specialist Breaks Out to Multi-Year High After Study Data - I Expect Further Price Increases!
Genmab (i.) is a European healthcare stock that combines the development of its own antibody technologies...
GameStop: Insider Purchases as Preparation for the Next Squeeze?
The GameStop stock (GME) has recently come back into the spotlight for speculative investors. Notably,...
Ondas: Drone Defense and Acquisitions Drive the Value of the Autonomy Platform - Citizens Announces $14 Price Target!
Citizens Research has Ondas Inc. (ONDS) initiated coverage on October 5 with an "Outperform" rating...
Vaxcyte: Phase 3 Success for VAX-31: Protection Against 31 Bacterial Strains Causes Stock to Rise by 50%
Vaxcyte targets prevention markets with protein conjugates. OPUS-1 data confirm the efficacy of VAX-31...
Thermo Fisher Scientific: Strategic Realignment and Margin Growth!
Thermo Fisher Scientific's diversified business model benefits from structural trends in biopharmaceutical...
Union Pacific: Norfolk Southern Integration Restructures U.S. Freight Network!
Union Pacific's business model increasingly focuses on the expansion into a transcontinental U.S. railroad...
Forgent Power Solutions: Three Undiscovered Profit Drivers Amid the AI Boom!
The boom in cloud services is consistently driving the demand for electrical infrastructure. Bernstein...
Nokia: New Orbit Alliances – Defense Business Fuels AI Strategy!
The model is increasingly focusing on AI and government infrastructure, supported by order intake of...
Sony: AI Upscaling as a Hidden Margin Driver for the PlayStation Division
Strong profitability in gaming and image sensors offsets moderately declining hardware sales. A QSSR...
LB Pharmaceuticals: Targeting a Multibillion-Dollar Market – How a Modified Drug Could Transform Psychiatry
LB Pharmaceuticals (LBRX) is pursuing a new therapeutic approach. LB-102 addresses schizophrenia and...
Kura Oncology: Insider Purchases and Pipeline Expansion as a Catalyst for JPMorgan's $30 Price Target
Kura Oncology (KURA) is making a strategic shift to become a commercial cancer therapeutic provider....
MLP SE: Forecast Increase Triggers Stock Rise to Multi-Year High!
In the last two months, I have frequently reported on the attractive starting position of the financial...
Adesso: GenAI Business Develops into a Measurable Growth Driver
Concerns about AI have recently burdened IT service providers and software stocks. This has also affected...